Capecitabina Zentiva 500 mg compresse rivestite con film.
Sponsors
Glaxosmithkline Research & Development Limited, Fondazione IRCCS Istituto Nazionale Dei Tumori
Conditions
MMRp/ MSS colon cancerPseudomyxoma peritonei patients with high tumor burden.
Phase 2
Metronomic neoadjuvant capecitabine and cyclophosphamide in huge (PCI>28) Pseudomyxoma peritonei (PMP) patients candidates to cytoreductive surgery (CRS) and hypertermic intraperitoneal chemotherapy (HIPEC).
RecruitingCTIS2024-514329-42-00
Start: 2024-11-22Target: 31Updated: 2025-12-03
A Phase 2, open label, randomized study of neoadjuvant dostarlimab plus CAPEOX versus CAPEOX in participants with previously untreated T4N0 or Stage III MMRp/ MSS colon cancer
RecruitingCTIS2024-513441-36-00
Start: 2024-11-27Target: 170Updated: 2025-12-18